加速神经母细胞瘤药物开发:第三届神经母细胞瘤药物开发战略论坛共识声明 Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum. PubMed 2025/06/12 发表Pediatr Blood CancerQ2 · IF 2.4(JCR 2025) 人群:儿童靶点:GD2技术:CAR-T神经母细胞瘤地区:美国地区:欧洲
靶向胶质母细胞瘤的嵌合抗原受体:现状与未来展望 Current and future perspectives of chimeric antigen receptors against glioblastoma. PubMed 2022/06/01 发表Immunother AdvQ2 · IF 4.4(JCR 2025) 靶点:CD70靶点:GD2技术:CAR-T技术:NK 细胞胶质母细胞瘤多发性骨髓瘤白血病